000 | 01350 a2200361 4500 | ||
---|---|---|---|
005 | 20250515060544.0 | ||
264 | 0 | _c20070515 | |
008 | 200705s 0 0 eng d | ||
022 | _a0269-8811 | ||
024 | 7 |
_a10.1177/0269881107076418 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKerwin, Robert | |
245 | 0 | 0 |
_aThe House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late? _h[electronic resource] |
260 |
_bJournal of psychopharmacology (Oxford, England) _cMar 2007 |
||
300 |
_a131-3 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAdvertising _xethics |
650 | 0 | 4 |
_aAntipsychotic Agents _xeconomics |
650 | 0 | 4 |
_aClinical Trials as Topic _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug Industry _xeconomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLobbying |
650 | 0 | 4 |
_aMarketing _xeconomics |
650 | 0 | 4 |
_aPatents as Topic _xlegislation & jurisprudence |
650 | 0 | 4 | _aPersuasive Communication |
650 | 0 | 4 | _aPolitics |
650 | 0 | 4 |
_aPractice Guidelines as Topic _xstandards |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aUnited Kingdom |
773 | 0 |
_tJournal of psychopharmacology (Oxford, England) _gvol. 21 _gno. 2 _gp. 131-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269881107076418 _zAvailable from publisher's website |
999 |
_c16886760 _d16886760 |